These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37410963)

  • 1. Clinical activities that contributed to the effectiveness of a cardiologist-pharmacist collaborative care model in managing diabetes.
    Lum ZK; Kng KK; Goh CEM; Sule AA; Gallagher PJ; Lee JY
    Int J Pharm Pract; 2023 Sep; 31(5):540-547. PubMed ID: 37410963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
    Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
    J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of multidisciplinary collaborative care versus usual care in the management of high-risk patients with diabetes in Singapore: Short-term results from a randomized controlled trial.
    Siaw MYL; Malone DC; Ko Y; Lee JY
    J Clin Pharm Ther; 2018 Dec; 43(6):775-783. PubMed ID: 29696669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a pharmacist-led diabetes management service in an endocrinology clinic.
    Parsiani R; Lundy R; Ahmann A; Joarder F; Castle J
    J Am Pharm Assoc (2003); 2022; 62(6):1855-1859. PubMed ID: 36089458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmacist-involved collaborative care on diabetes management in a primary healthcare setting using real-world data.
    Abdulrhim S; Awaisu A; Ibrahim MIM; Diab MI; Hussain MAM; Al Raey H; Ismail MT; Sankaralingam S
    Int J Clin Pharm; 2022 Feb; 44(1):153-162. PubMed ID: 34637104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Collaborative Goal Setting With Enhanced Education for Managing Diabetes-Associated Distress and Hemoglobin A1c Levels: A Randomized Clinical Trial.
    Woodard L; Amspoker AB; Hundt NE; Gordon HS; Hertz B; Odom E; Utech A; Razjouyan J; Rajan SS; Kamdar N; Lindo J; Kiefer L; Mehta P; Naik AD
    JAMA Netw Open; 2022 May; 5(5):e229975. PubMed ID: 35507345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Pharmacist and Physician Collaboration in the Treatment of Type 2 Diabetes Mellitus With Severe Insulin Resistance Using U-500 Insulin.
    Hess R; Brandon S; Johnson F
    South Med J; 2016 Nov; 109(11):690-693. PubMed ID: 27812708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
    Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
    J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial.
    Suppapitiporn S; Chindavijak B; Onsanit S
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S134-41. PubMed ID: 16623018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.
    Konnyu KJ; Yogasingam S; Lépine J; Sullivan K; Alabousi M; Edwards A; Hillmer M; Karunananthan S; Lavis JN; Linklater S; Manns BJ; Moher D; Mortazhejri S; Nazarali S; Paprica PA; Ramsay T; Ryan PM; Sargious P; Shojania KG; Straus SE; Tonelli M; Tricco A; Vachon B; Yu CH; Zahradnik M; Trikalinos TA; Grimshaw JM; Ivers N
    Cochrane Database Syst Rev; 2023 May; 5(5):CD014513. PubMed ID: 37254718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Pharmacist-Led Drug Therapy Management Services on HbA
    Hernández-Muñoz JJ; De Santiago AC; Cedrone SZ; Verduzco RA; Bazan DZ
    J Pharm Pract; 2021 Dec; 34(6):857-863. PubMed ID: 32495714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
    Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.
    Mehuys E; Van Bortel L; De Bolle L; Van Tongelen I; Annemans L; Remon JP; Giri M
    J Clin Pharm Ther; 2011 Oct; 36(5):602-13. PubMed ID: 21143256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist-Led Diabetes Control Intervention and Health Outcomes in Hispanic Patients With Diabetes.
    Narain KDC; Moreno G; Bell DS; Chen L; Tseng CH; Follett RW; Skootsky S; Mangione CM
    JAMA Netw Open; 2023 Sep; 6(9):e2335409. PubMed ID: 37768663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes.
    McAdam-Marx C; Dahal A; Jennings B; Singhal M; Gunning K
    J Manag Care Spec Pharm; 2015 Jun; 21(6):452-68. PubMed ID: 26011547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial.
    Siaw MYL; Ko Y; Malone DC; Tsou KYK; Lew YJ; Foo D; Tan E; Chan SC; Chia A; Sinaram SS; Goh KC; Lee JY
    J Clin Pharm Ther; 2017 Aug; 42(4):475-482. PubMed ID: 28449205
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.